Package Leaflet: Information for the User
Atenolol Aurovitas 100 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Atenolol Aurovitas contains a medication called atenolol. It belongs to a group of medications known as beta blockers.
Atenolol tablets are used for:
Do not take Atenolol Aurovitas:
Warnings and precautions
Consult your doctor or pharmacist before starting to take atenolol if:
If you are unsure whether any of the above applies to you, consult with your doctor or pharmacist before taking this medication.
Taking Atenolol Aurovitas with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication. This includes over-the-counter medications and herbal medications. This is because atenolol may affect how other medications work, and some medications may have an effect on atenolol.
In particular, inform your doctor if you are taking any of the following medications:
Operations and X-rays
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
It is likely that your medication will not affect your ability to drive or use tools or machines.
However, it is best to wait and see how your medication affects you before trying these activities. If you feel dizzy or tired while taking this medication, do not drive or use tools or machines.
Sodium
This medication contains less than 23 mg of sodium (1mmol) per tablet; this is, essentially "sodium-free".
Important information about some of the components of atenolol:
It is reported to athletes that this medication contains a component that may result in a positive analytical result for doping control
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Adults
High blood pressure (hypertension):The recommended dose is
Chest pain (angina):The recommended dose is 100 mg per day or 50 mg twice a day.
Irregular heartbeats (arrhythmias):The recommended dose is
50 mg and 100 mg per day.
Early treatment of a heart attack (myocardial infarction):The recommended dose is 50 mg to 100 mg per day.
Older adults
If you are an older adult, your doctor may decide to give you a lower dose, especially if you have kidney problems.
People with severe kidney problems
If you have severe kidney problems, your doctor may prescribe a lower dose.
Use in children
This medication should not be given to children.
If you take more Atenolol Aurovitas than you should
If you take more atenolol tablets than prescribed by your doctor, consult a doctor or go to the hospital immediately.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Atenolol Aurovitas
If you forget to take a dose, take it as soon as you remember.
If you interrupt treatment with Atenolol Aurovitas
Do not stop taking the atenolol tablets without consulting your doctor. You may need to stop taking it gradually.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Allergic reactions:
If you have an allergic reaction, consult a doctor immediately. Symptoms may include raised bumps on the skin (hives) or swelling of the face, lips, mouth, tongue, or throat.
Other possible side effects
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people))
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from available data)
Conditions that may worsen
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medications should not be thrown into the drains or trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy.Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofAtenolol Aurovitas
Each tablet contains 100 mg of atenolol.
Tablet core: magnesium carbonate (heavy), cornstarch, sodium lauryl sulfate, gelatin, magnesium stearate.
Tablet coating: hypromellose 2910, talc, macrogol 6000, and titanium dioxide (E171).
Appearance of the product and contents of the package
Coated tablet.
White, round, biconvex coated tablets, engraved with ‘A100’ on one face and with a notch on the other. The tablet can be divided into equal doses. [size: approximately 10.5 mm].
Atenolol Aurovitas coated tablets are available in transparent PVC/PVdC-Aluminum blister packs.
Pack sizes:30, 42, 50, 60, and 90 coated tablets.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer responsible
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Tel.: 91 630 86 45
Fax: 91 630 26 64
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
O
Generis Farmacêutica S.A.
Rua Joao de Deus, nº 19 Amadora, Venda Nova
2700-487
Portugal
O
Arrow Generiques-Lyon
26 avenue Tony Garnier, Lyon, 69007
France
This medicine is authorized in the member states of the European Economic Area with the following names:
France:Atenolol Arrow lab 100 mg coated tablet
Italy:Atenololo Aurobindo Italia
Portugal:Atenolol Generis Phar
Spain:Atenolol Aurovitas 100 mg coated tablets EFG
Last review date of this leaflet: May 2019
The detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es)
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.